FMS Q2 2022 Earnings Report — Fresenius Medical Care AG & Co. KGaA Revenue & Financial Results | Market Cap Arena

Fresenius Medical Care AG & Co. KGaAFMS

Q2 2022 Earnings

Reported June 30, 2022

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	Q2 2022	Q1 2022	Q2 2021	QoQ Change	YoY Change
Revenue	$5.6B	—	—	—	—
Op. Income	$398M	—	—	—	—
Gross Margin	26.2%	—	—	—	—
Net Margin	3.1%	—	—	—	—
EPS (Diluted)	$0.15	—	—	—	—
Free Cash Flow	$677M	—	—	—	—

Revenue Flow

Item	Amount
REVENUE	$5.6B
Cost of Revenue	$4.1B
GROSS PROFIT	$1.5B
R&D Expenses	$65M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$886M
Other Expenses	$107M
Operating Expenses	$1.1B
Cost & Expenses	$5.2B
OPERATING INCOME	$398M
Interest Income	$15M
Interest Expense	$99M
Other Income/Expenses	-$84M
INCOME BEFORE TAX	$314M
Income Tax Expense	$74M
Net Income from Continuing Ops	$241M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$172M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$172M
D&A	$493M
EBIT	$413M
EBITDA	$906M
EPS	$0
EPS Diluted	$0

Income Statement

Item	Amount
REVENUE	$5.6B
Cost of Revenue	$4.1B
GROSS PROFIT	$1.5B
R&D Expenses	$65M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$886M
Other Expenses	$107M
Operating Expenses	$1.1B
Cost & Expenses	$5.2B
OPERATING INCOME	$398M
Interest Income	$15M
Interest Expense	$99M
Other Income/Expenses	-$84M
INCOME BEFORE TAX	$314M
Income Tax Expense	$74M
Net Income from Continuing Ops	$241M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$172M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$172M
D&A	$493M
EBIT	$413M
EBITDA	$906M
EPS	$0
EPS Diluted	$0

Cash Flow Statement

Item	Amount
Net Income	$172M
Depreciation & Amortization	$493M
Stock-Based Compensation	$0
Deferred Income Tax	$0
Other Non-Cash Items	$127M
Change in Working Capital	$86M
OPERATING CASH FLOW	$879M
Capital Expenditure	-$201M
Acquisitions (Net)	-$29M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	-$1M
NET CASH FROM INVESTING	-$231M
Net Debt Issuance	-$715M
Common Stock Repurchased	$0
Common Dividends Paid	-$462M
Other Financing Activities	$326M
NET CASH FROM FINANCING	-$851M
FREE CASH FLOW	$677M
Net Change in Cash	-$174M

Balance Sheet

Item	Amount
Cash & Equivalents	$1.2B
Short-Term Investments	$0
Net Receivables	$4.4B
Inventory	$2.7B
Other Current Assets	$1.2B
TOTAL CURRENT ASSETS	$9.5B
PP&E (Net)	$10.4B
Goodwill	$18.2B
Intangible Assets	$1.8B
Long-Term Investments	$859M
Tax Assets	$0
Other Non-Current Assets	$1.4B
TOTAL NON-CURRENT ASSETS	$32.7B
TOTAL ASSETS	$42.2B
Account Payables	$1.1B
Short-Term Debt	$1.7B
Deferred Revenue	$0
Other Current Liabilities	$4.2B
TOTAL CURRENT LIABILITIES	$8.0B
Long-Term Debt	$8.5B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$1.1B
Other Non-Current Liabilities	$1.5B
TOTAL NON-CURRENT LIABILITIES	$16.1B
TOTAL LIABILITIES	$24.1B
Common Stock	$343M
Additional Paid-In Capital	$3.4B
Retained Earnings	$12.6B
Treasury Stock	$0
Accum. Other Comp. Income	$40M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$16.4B
Minority Interest	$1.6B
TOTAL EQUITY	$18.1B
TOTAL LIABILITIES & EQUITY	$42.2B
Total Debt	$16.0B
Net Debt	$14.8B